Trillium Therapeutics

+$0.47 (+2.62%) Today
$0.00 (0.00%) As of 12:41 AM UTC after-hours

Why Robinhood?

You can watch TRIL and buy or sell other stocks, options, and ETFs commission-free!

About TRIL

Trillium Therapeutics Inc. operates as a biopharmaceutical research and development company. It focuses on the immune system and its regulation.

CEO
Jan Skvarka, PhD, MBA
Employees
—
Headquarters
Mississauga, Ontario
Founded
2004

TRIL Key Statistics

Market cap
1.94B
Price-Earnings ratio
74.87
Dividend yield
—
Average volume
3.67M
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$20.96
52 Week low
$5.80

TRIL Earnings

-$0.90
-$0.10
$0.69
$1.49
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 12, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure